Diversity of mechanisms conferring resistance to β-lactams among OXA-23-producing Acinetobacter baumannii clones

Diagnostic Microbiology and Infectious Disease

Volumn 85, Issue 1, 2016, Pages 90-97

  Provasi Cardoso, Juliana ^a   Cayô, Rodrigo ^a   Girardello, Raquel ^a   Gales, Ana Cristina ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acinetobacter baumannii; AmpC; Carbapenems; Efflux pumps; Extended spectrum cephalosporins; Molecular epidemiology; OXA 23; Porins

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; MEROPENEM; MINOCYCLINE; POLYMYXIN B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ADEB GENE; AMPC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARO GENE; CLONE; DOWN REGULATION; DRUG EFFECT; GENE OVEREXPRESSION; GENE SEQUENCE; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; BRAZIL; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PHYLOGEOGRAPHY; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PHYLOGEOGRAPHY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84959919300     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2016.01.018     Document Type: Article

References (44)

1. Ben R.J., Yang M.C., Hsueh J.C., Shiang J.C., Chien S.T. Molecular characterization of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Int J Antimicrob Agents 2011, 38:403-408.
2. Bishburg E., Bishburg K. Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii. Int J Antimicrob Agents 2009, 34:395-401.
3. Bou G., Martínez-Beltrán J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2000, 44:428-432.
4. Brazilian Health Surveillance Agency (ANVISA) Boletim Informativo: Segurança do Paciente e Qualidade em Serviço de Saúde n° 9: Relatório da resistência microbiana em infecções primárias de corrente sanguínea confirmadas laboratorialmente relacionadas ao uso de cateter venoso central em unidades de terapia intensiva 2013, [Accessed on 04 September 2015. Available at: http://portal.anvisa.gov.br/wps/wcm/connect/a48d080049a53b4e98df9ada875a0177/boletim_seguranca_paciente9.pdf?MOD = AJPERES].
5. Carneiro M., Barbosa P.I., Vespero E.C., Tanita M.T., Carrilho C.M., Perugini M., et al. Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia. Am J Infect Control 2010, 38:667-669.
6. Catel-Ferreira M., Coadou G., Molle V., Mugnier P., Nordmann P., Siroy A., et al. Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. J Antimicrob Chemother 2011, 66:2053-2056.
7. Chagas T.P., Carvalho K.R., de Oliveira Santos I.C., Carvalho-Assef A.P., Asensi M.D. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis 2014, 79:468-472.
8. Clinical Laboratory Standard Institute (CLSI) Performance standards for antimicrobial susceptibility testing. Informational supplement M100-S25 2015, CLSI, Wayne, PA. 25th ed.
9. Coelho-Souza T., Reis J.N., Martins N., Martins I.S., Menezes A.O., Reis M.G., et al. Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil. Clin Microbiol Infect 2013, 19:E241-E244.
10. Dalla-Costa L.M., Coelho J.M., Souza H.A., Castro M.E., Stier C.J., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003, 41:3403-3406.
11. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010, 5:e10034.
12. Fehlberg L.C., da Silva Nogueira K., Cayô da Silva R., Nicoletti A.G., Palmeiro J.K., Gales A.C., et al. Detection of PER-2-producing Enterobacter cloacae in a Brazilian liver transplantation unit. Antimicrob Agents Chemother 2014, 58:1831-1832.
13. Fernández-Cuenca F., Smani Y., Gómez-Sánchez M.C., Docobo-Pérez F., Caballero-Moyano F.J., Domínguez-Herrera J., et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. Int J Antimicrob Agents 2011, 38:548-549.
14. OXA-23 gene. BMC Microbiol 2013, 13:245.
15. Furtado G.H., Cavalcante A.C., Medeiros E.A., Gales A.C., Oliveira V.G., Girardelo R. Bloodstream infections with OXA-23-producing Acinetobacter baumannii isolates in a university-affiliated hospital in Brazil: epidemiology and clinical outcomes. Am J Infect Control 2011, 39:706-708.
16. Gales A.C., Castanheira M., Jones R.N., Sader H.S. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Sueveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012, 73:354-360.
17. Gales A.C., Jones R.N., Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 2006, 12:315-321.
18. Grosso F., Carvalho K.R., Quinteira S., Ramos A., Carvalho-Assef A.P., Asensi M.D., et al. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?. J Antimicrob Chemother 2011, 66:62-65.
19. Hamidian M., Hall R.M. ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistance. J Antimicrob Chemother 2013, 68:2682-2683.
20. Hamidian M., Hall R.M. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. J Antimicrob Chemother 2014, 69:77-80.
21. Higgins P.G., Lehmann M., Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010, 35:305.
22. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007, 60:1163-1167.
23. La Scola B., Gundi V.A., Khamis A., Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006, 44:827-832.
24. Lee Y., Kim C.K., Lee H., Jeong S.H., Yong D., Lee K. A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob Agents Chemother 2011, 55:361-363.
25. Martins A.F., Kuchenbecker R.S., Pilger K.O., Pagano M., Barth A.L., CMCIES-PMPA/SMS Task Force High endemic levels of multidrug-resistant Acinetobacter baumannii among hospitals in southern Brazil. Am J Infect Control 2012, 40:108-112.
26. Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009, 63:55-59.
27. Mendes R.E., Kiyota K.A., Monteiro J., Castanheira M., Andrade S.S., Gales A.C., et al. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007, 45:544-547.
28. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010, 16:35-40.
29. Mussi M.A., Limansky A.S., Viale A.M. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother 2005, 49:1432-1440.
30. Paton R., Miles R.S., Hood J., Amyes S.G., Miles R.S., Amyes S.G. ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993, 2:81-87.
31. Peleg A.Y., Adams J., Paterson D.L. Tigecycline efflux as a mechanism for non susceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:2065-2069.
32. Poirel L., Figueiredo S., Cattoir V., Carattoli A., Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008, 52:1252-1256.
33. Poirel L., Naas T., Nordmann P. Diversity, epidemiology and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010, 54:24-38.
34. Rodríguez-Martínez J.M., Nordmann P., Ronco E., Poirel L. Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother 2010, 54:3484-3488.
35. Rumbo C., Tomás M., Fernández Moreira E., Soares N.C., Carvajal M., Santillana E., et al. The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect Immun 2014, 82:4666-4680.
36. Schimith Bier K.E., Luiz S.O., Scheffer M.C., Gales A.C., Paganini M.C., Nascimento A.J., et al. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Am J Infect Control 2010, 38:308-314.
37. Seifert H., Dolzani L., Bressan R., van der Reijden T., van Strijen B., Stefanik D., et al. Standardization and inter-laboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4328-4335.
38. Smani Y., Fàbrega A., Roca I., Sánchez-Encinales V., Vila J., Pachón J. Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother 2014, 58:1806-1808.
39. Stietz M.S., Ramírez M.S., Vilacoba E., Merkier A.K., Limansky A.S., Centrón D., et al. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 2013, 14:294-301.
40. Sugawara E., Nikaido H. OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol 2012, 194:4089-4096.
41. Vila J., Martí S., Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007, 59:1210-1215.
42. Yoon E.J., Courvalin P., Grillot-Courvalin C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother 2013, 57:2989-2995.
43. Zander E., Chmielarczyk A., Heczko P., Seifert H., Higgins P.G. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. J Antimicrob Chemother 2013, 68:308-311.
44. Zander E., Nemec A., Seifert H., Higgins P.G. Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J Clin Microbiol 2012, 50:1900-1904.